Anebulo Pharmaceuticals, Inc.
Hedge Funds Holdings

Last updated:

Anebulo Pharmaceuticals, Inc.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 2.94% of the total amount of its stocks outstanding. This makes up a total of 686.02K shares of Anebulo Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -90.26% or -6.36M shares fewer. As for the holding position changes, 75% (3) of current hedge fund investors increased the number of shares held, 25% (1) of current holders sold a part of the shares held, and 75% (3) closed the holdings completely.

Hedge funds holding Anebulo Pharmaceuticals (Q2 2021 – Q1 2023)

Number of hedge funds
Q2 2021 8
Q3 2021 7
Q4 2021 8
Q1 2022 8
Q2 2022 8
Q3 2022 10
Q4 2022 12
Q1 2023 4

Hedge funds changes in Anebulo Pharmaceuticals positions (Q2 2021 – Q1 2023)

Changes in positions
Q2 2021 80000
Q3 2021 01411
Q4 2021 12203
Q1 2022 12311
Q2 2022 12113
Q3 2022 22501
Q4 2022 31314
Q1 2023 0313-3

Top 50 hedge fund holders of Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB)

Hedge fund Value Shares owned Portfolio share
22NW, LP 14.18M 5.06M 8.023%
LVW ADVISORS, LLC 1.89M 674.96K 0.422%
NANTAHALA CAPITAL MANAGEMENT, LLC 1.43M 511.07K 0.093%
MANGROVE PARTNERS 1.11M 399.21K 0.065%
IKARIAN CAPITAL, LLC 437K 156.20K 0.087%
BOOTHBAY FUND MANAGEMENT, LLC 48K 17.31K 0.001%
TOWER RESEARCH CAPITAL LLC (TRC) 21K 7.33K 0.000%
BLACKROCK INC. Larry Fink 20K 7.13K 0.000%
UBS GROUP AG 8K 2.78K 0.000%
MORGAN STANLEY 2K 600 0.000%